Showing 41-50 of 3039 results for "".
Breaking News from the ASCRS Meeting in Los Angeles
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-ascrs-meeting-in-los-angeles/37082/EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report – Increasing Access to Care Through the Cure Blindness Project
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-increasing-access-to-care-through-the-cure-blindness-project/37067/Leaders from Cure Blindness Project discuss efforts to restore vision and prevent avoidable blindness in underserved communities around the world. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: OWL Celebrates 20th Anniversary
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-owl-celebrates-20th-anniversary/37060/Executives from Ophthalmic World Leaders discuss the history and goals of thee organization as it celebrates its 20th anniversary. Learn more about your ad choices. Visit megaphone.fm/adchoicesIntermediate AMD Identified: Now What?
https://modernod.com/topics/retina/intermediate-amd-identified-now-what/38339/Finding early signs of wet age-related macular degeneration can make the difference between vision preservation and permanent vision loss.Giving a Nod to Nodular Episcleritis
https://modernod.com/topics/corneaanterior-segment/giving-a-nod-to-nodular-episcleritis/38655/Systemic workup may be warranted to rule out a more serious condition.Alcon Announces Plans to Acquire Lensar
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-announces-plans-to-acquire-lensar/37077/Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoThen, Now, and Tomorrow: Evolving the Management of Diabetic Retinopathy and the Role of the Optometrist
https://modernod.com/mod-issues/supplements-inserts/then-now-and-tomorrow-evolving-the-management-of-diabetic-retinopathy-and-the-role-of-the-optometrist/37955/First Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesFirst Robotic Cataract Surgery Performed
https://modernod.com/podcasts/eyewire-news-the-podcast/first-robotic-cataract-surgery-performed/39875/Uday Devgan, MD, shares his experience performing the world’s first robotic cataract surgery; Konan Medical receives CE Mark for its objectiveFIELD Analyzer perimetry device; and Biotech Healthcare launches a new full visual range EDOF IOL. Learn more about your ad choices. Visit megaphone.fm/adchoCE Certification for New Glaucoma Surgical Implant
https://modernod.com/podcasts/eyewire-news-the-podcast/ce-certification-for-new-glaucoma-surgical-implant/39868/Ciliatech obtains CE certification for the Intercil Uveal Spacer surgical implant; Zeiss receives CE mark for a new device that uses AI to automate OCT assessment; and the FDA extends the target action dates for two Eylea HD submissions. Learn more about your ad choices. Visit megaphone.fm/adchoic